Fig. 1From: Effectiveness of triple therapy with direct-acting antivirals for hepatitis C genotype 1 infection: application of propensity score matching in a national HCV treatment registryFlow diagram illustrating the outcomes of patients ever started on treatment with TPV/PR and BOC/PR. #Fifteen patients discontinued treatment prematurely but achieved a SVR24. Therefore, in total n = 215/309 (70%) (n = 200/222 and n = 15/87) achieved a SVR24Back to article page